ImageneBio Inc (IMA)

• Market cap: $93.9M
• 1 day: -3.56%
• 5 days: 0.96%
• 1 month: -2.33%
• 3 months: -49.4%
• 6 months: -42.15%
• Year to date: -57.58%
• 1 year: -59.3%
• 5 years: -97.81%
• 10 years: -97.81%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.